TANG CAPITAL PARTNERS LP 13D and 13G filings for TCR2 Therapeutics Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:00 pm Sale |
2023-12-31 | 13G | TCR2 Therapeutics Inc. TCRR |
TANG CAPITAL PARTNERS LP | 0 0.000% |
-4,215,864 (Position Closed) |
Filing |
| 2023-05-05 4:37 pm Purchase |
2023-05-03 | 13G | TCR2 Therapeutics Inc. TCRR |
TANG CAPITAL PARTNERS LP | 4,215,864 10.700% |
1,476,917 (+53.92%) |
Filing |
| 2023-02-14 4:00 pm Sale |
2022-12-31 | 13G | TCR2 Therapeutics Inc. TCRR |
TANG CAPITAL PARTNERS LP | 2,738,947 7.100% |
-61,053 (-2.18%) |
Filing |
| 2022-03-04 4:00 pm Purchase |
2022-02-22 | 13G | TCR2 Therapeutics Inc. TCRR |
TANG CAPITAL PARTNERS LP | 2,800,000 7.300% |
2,800,000 (New Position) |
Filing |